Key mechanisms include the induction of a tumor-suppressive gene network involving thyroid differentiation markers (e.g., NIS/SLC5A5, TG, PAX8) and repression of oncogenic drivers like RUNX2 [118]. This evidence concerns the gene SLC5A5 and neoplasm.